Open Government Portal
MaintenanceWe are performing scheduled maintenance from 8:00am to 12:00pm, Monday, December 4th, Eastern time.
As of fiscal year 2019 to 2020 and under the new Treasury Board Secretariat Policy on Results (https://www.tbs-sct.gc.ca/pol/doc-eng.aspx?id=31300), all departments have implemented the new Departmental Results Framework. This framework, which replaces the Program Alignment Architecture (PAA), consists of departmental core responsibilities and their related program inventory. These codes are used to reflect the resources allocated to the achievement of government objectives. The format of these codes is composed of a 5 digit field: 3 alpha (capital letter) and 2 numeric digit codes.
ZZZ00 - represents a core responsibility. The first three digits are capital letters and the last two …
The Public Servants Disclosure Protection Act (PSDPA) offers federal public sector employees and other persons a secure and confidential process for the disclosure of serious wrongdoing in the workplace, as well as protection against reprisal.
Information to which public access is provided must describe: the wrongdoing, including the identity of the person found to have committed it if necessary in order to describe the wrongdoing adequately; the recommendations, if any, set out in any report made to the chief executive; and any corrective action taken by the chief executive or the reasons why no corrective action was taken.
Building a comprehensive data inventory as required by section 6.3 of the Directive on Open Government:
“Establishing and maintaining comprehensive inventories of data and information resources of business value held by the department to determine their eligibility and priority, and to plan for their effective release.”
Creating a data inventory is among the first steps in identifying federal data that is eligible for release. Departmental data inventories has been published on the Open Government portal, Open.Canada.ca, so that Canadians can see what federal data is collected and have the opportunity to indicate what data is of most interest to them, …
The Food Source Contribution Table (FSCT) provides estimates of how much various food groups and subgroups contribute to Canadians’ intakes of energy and selected nutrients using data collected in the 2015 Canadian Community Health Survey (CCHS) - Nutrition.
Two different datasets are available. The first file provides data for recipes as a whole along with food consumed on its own. The second file provides data for recipes broken down into their ingredients along with food consumed on its own.
The User Guide and Food Group Lists provide detailed information to facilitate use of the FSCT.
This guidance document addresses the development of contraceptive products, intended for use by women during their reproductive years, which contain sex steroids as active ingredient(s).
These guidelines have been developed by a Therapeutic Products Programme's Working Group for the Toxicological Assessment of Contraceptive Steroids in close consultation with several experts in the fields of toxicology, pathology and reproductive physiology.
This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA.
This guidance is intended to harmonize and to update the prescribing information for nonsteroidal anti-inflammatory drugs () indicated for controlling pain and inflammation associated with rheumatic diseases and other less severe conditions.
Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.
Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada.